ArticleJournal of clinical medicine2022

Safety, Feasibility and Technical Considerations from a Prospective, Observational Study-CIREL: Irinotecan-TACE for CRLM in 152 Patients.

Thomas Helmberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.